Table 1.
| Subject | ART | Week of VF | HIV-1 VL at VF (c/mL) | Plasma tropism at VF (FPR,%) | Recent adherence at VF (%) | Resistance mutations at VF (IAS-USA 2013) | ART after VF | Regained VL <50 c/mL |
|---|---|---|---|---|---|---|---|---|
| 1 | MVC+TDF/FTC | 4 | 300 | X4 (0.1) | 100 | NA | DRV/r+ETV | Yes |
| 2 | MVC+TDF/FTC | 12 | 14,102 | X4 (1.3) | 100 | RT: 41L, 67N, 184V, 215Y PR: 36I, 63P | TDF/FTC+ETV | Yes |
| 3 | MVC+ABC/3TC | 12 | 67 | R5 (86.8) | 100 | RT: 90I, 184I PR: 64V | TDF+DRV/r+EFV | Yes |
| 4 | MVC+TDF/FTC | 12 | 59 | NA | 100 | NA | Continued with MVC+TDF/FTC | Yes |
| 5 | MVC+TDF/FTC | 36 | 90 | R5 (79.7) | 100 | NA | Continued with MVC+TDF/FTC | Yes |